Corrigendum: Epigenetic immune monitoring for COVID-19 disease course prognosis

• Björn Samans,
• Björn Samans,
• Marta Rosselló Chornet,
• Araceli Rosselló Chornet,
• Janine Jung,
• Konstantin Schildknecht,
• Laura Lozza,
• Lourdes Alos Zaragoza,
• Javier Hernández Laforet,
• Nina Babel,
• Sven Olek

Affiliations

Björn Samans

Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany

Björn Samans

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany

Marta Rosselló Chornet

Department of Anesthesiology and Resuscitation, Consortium General University Hospital of Valencia, Valencia, Spain

Araceli Rosselló Chornet

Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany

Janine Jung

Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany

Konstantin Schildknecht

Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany

Laura Lozza

Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany

Lourdes Alos Zaragoza

Department of Anesthesiology and Resuscitation, Consortium General University Hospital of Valencia, Valencia, Spain

Javier Hernández Laforet

Department of Anesthesiology and Resuscitation, Consortium General University Hospital of Valencia, Valencia, Spain

Nina Babel

Center for Translational Medicine, Medical Clinic 1, Marien Hospital Herne, University Hospitals of the Ruhr-University of Bochum, Herne, Germany

Sven Olek

Ivana Türbachova Laboratory for Epigenetics, Epiontis, Precision for Medicine GmbH, Berlin, Germany